Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-05 4:10 pm Sale | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital LLC | 2,670,930 5.9% | -94,600 (-3.42%) | View |
| 2024-02-14 6:00 pm Unchanged | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital LLC | 448,101 4.6% | 0 (Unchanged) | View |
| 2023-02-14 12:57 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital LLC | 2,765,530 12.5% | 74,420 (+2.77%) | View |
| 2023-02-14 11:26 am Sale | 13G | X4 PHARMACEUTICALS INC XFOR | Ikarian Capital LLC | 349,133 0.3% | -1,915,358 (-84.58%) | View |
| 2023-02-14 11:03 am Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | Ikarian Capital LLC | 460,416 1.3% | -1,289,627 (-73.69%) | View |
| 2023-02-14 11:02 am Sale | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital LLC | 448,101 5.2% | -48,655 (-9.79%) | View |
| 2022-02-14 4:43 pm Sale | 13G | X4 PHARMACEUTICALS INC XFOR | Ikarian Capital LLC | 2,264,491 8.1% | -360,497 (-13.73%) | View |
| 2022-02-14 4:41 pm Sale | 13G | ATYR PHARMA INC LIFE | Ikarian Capital LLC | 35,048 0.1% | -853,532 (-96.06%) | View |
| 2022-02-14 4:39 pm Sale | 13G | PROTARA THERAPEUTICS INC TARA | Ikarian Capital LLC | 279,256 2.5% | -370,286 (-57.01%) | View |
| 2022-02-14 4:37 pm Sale | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital LLC | 2,691,110 13.8% | -25,730 (-0.95%) | View |
| 2022-02-14 4:36 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | Ikarian Capital LLC | 1,750,043 5.9% | -86,502 (-4.71%) | View |
| 2022-02-14 4:36 pm Sale | 13G | ODONATE THERAPEUTICS INC ODT | Ikarian Capital LLC | 1,340,631 3.5% | -645,781 (-32.51%) | View |
| 2022-02-14 4:35 pm Sale | 13G | SCPHARMACEUTICALS INC SCPH | Ikarian Capital LLC | 901,362 3.3% | -564,785 (-38.52%) | View |
| 2022-02-14 4:34 pm Unchanged | 13G | SCIENCE 37 HLDGS INC SNCE | Ikarian Capital LLC | 0 0% | 0 (Unchanged) | View |
| 2022-02-14 4:34 pm Sale | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Ikarian Capital LLC | 99,422 1% | -300,578 (-75.14%) | View |
| 2022-02-14 4:32 pm Sale | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital LLC | 496,756 5.9% | -3,244 (-0.65%) | View |
| 2022-02-14 4:32 pm Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Ikarian Capital LLC | 36,576 0.2% | -1,027,385 (-96.56%) | View |
| 2022-02-14 4:31 pm Sale | 13G | MILLENDO THERAPEUTICS INC MLND | Ikarian Capital LLC | 58,803 0.9% | -1,289,218 (-95.64%) | View |
| 2022-02-14 4:30 pm Sale | 13G | LYRA THERAPEUTICS INC LYRA | Ikarian Capital LLC | 394,536 3% | -420,828 (-51.61%) | View |
| 2021-09-17 3:00 pm Purchase | 13G | ATYR PHARMA INC LIFE | Ikarian Capital LLC | 888,580 5.3% | 888,580 (New Position) | View |